Updates | Pfizer

Pfizer to Share Oncology Advancements at ASCO Annual Meeting

Read more about Pfizer to Share Oncology Advancements at ASCO Annual Meeting

Cancer remains one of the greatest health challenges of our lifetime. It steals precious moments and robs us of our passions and dreams. But at Pfizer, we're up for the challenge. Because while cancer never rests, neither do we.

Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission

Read more about Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission

NEW YORK and MAINZ, GERMANY, MAY 26, 2023 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver COVID-19 vaccines to the European Union.

Research!America Offers $200k Discovery | Innovation | Health Prize for COVID-19 Innovator

Read more about Research!America Offers $200k Discovery | Innovation | Health Prize for COVID-19 Innovator

Breakthroughs like the COVID-19 vaccine don’t just materialize out of nowhere. They’re borne from bold visions, buoyed by constant collaboration, and realized only through persistence, perseverance, and hard work.

Events in NYC and Italy Spotlight Disability Inclusion

Read more about Events in NYC and Italy Spotlight Disability Inclusion

When you’re in the business of breakthroughs, you want to work with the best. While great talent comes from all backgrounds, they don’t all have the same access to professional opportunities or to environments where they’ll thrive.

Global and U.S. Agencies Declare End of COVID-19 Emergency

Read more about Global and U.S. Agencies Declare End of COVID-19 Emergency

On May 5, more than three years since COVID-19 was designated as a pandemic, the World Health Organization (WHO) declared an end to the global Public Health Emergency (PHE) for COVID-19.

Pfizer Sets New Ambition: Changing a Billion Lives a Year by 2027

Read more about Pfizer Sets New Ambition: Changing a Billion Lives a Year by 2027

In April, Pfizer CEO Albert Bourla stood centerstage at Pfizer’s brand-new Hudson Yards headquarters in New York, NY and unveiled the company’s brand-new “purpose blueprint.”

Ready to Respond: Pfizer’s Zithromax® Program & Covid-19

Read more about Ready to Respond: Pfizer’s Zithromax® Program & Covid-19

Hundreds of colleagues at Pfizer and partner manufacturing sites have come together to respond to the sudden and urgent need for Zithromax® around the world. The commitment to excellence and equity have driven a global response to ensure supply of one of Pfizer’s essential medicines.

Distributing Our COVID-19 Vaccine to the World

Read more about Distributing Our COVID-19 Vaccine to the World

An Open Letter from Pfizer Chairman and CEO Dr. Albert Bourla

How Pfizer is Responding to the COVID-19 Pandemic

Read more about How Pfizer is Responding to the COVID-19 Pandemic

Pfizer recognizes the public concern in relation to the current situation, which continues to evolve.

COVID-19 Vaccine Maker Pledge

Read more about COVID-19 Vaccine Maker Pledge

The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and Sanofi, have made a historic pledge to the world, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential regulatory filings and approvals of the first COVID-19 vaccines.

Subscribe to Updates